These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 26489663)

  • 21. Short- and Long-term Cognitive Outcomes in Patients With Major Depression Treated With Electroconvulsive Therapy.
    Vasavada MM; Leaver AM; Njau S; Joshi SH; Ercoli L; Hellemann G; Narr KL; Espinoza R
    J ECT; 2017 Dec; 33(4):278-285. PubMed ID: 28617690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized, crossover comparison of ketamine and electroconvulsive therapy for treatment of major depressive episodes: a Canadian biomarker integration network in depression (CAN-BIND) study protocol.
    Phillips JL; Jaworska N; Kamler E; Bhat V; Blier J; Foster JA; Hassel S; Ho K; McMurray L; Milev R; Moazamigoudarzi Z; Placenza FM; Richard-Devantoy S; Rotzinger S; Turecki G; Vazquez GH; Kennedy SH; Blier P;
    BMC Psychiatry; 2020 Jun; 20(1):268. PubMed ID: 32487236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapid antidepressant effects of repeated doses of ketamine compared with electroconvulsive therapy in hospitalized patients with major depressive disorder.
    Ghasemi M; Kazemi MH; Yoosefi A; Ghasemi A; Paragomi P; Amini H; Afzali MH
    Psychiatry Res; 2014 Feb; 215(2):355-61. PubMed ID: 24374115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Role of Baseline Cognitive Function in the Neurocognitive Effects of Electroconvulsive Therapy in Depressed Elderly Patients.
    Dybedal GS; Tanum L; Sundet K; Bjølseth TM
    Clin Neuropsychol; 2015; 29(4):487-508. PubMed ID: 26029851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Episodic Visual Learning/Memory and Attentional Flexibility in Patients With Major Depressive Disorder After Clinically Effective Electroconvulsive Therapy.
    Kalogerakou S; Oulis P; Anyfandi E; Konstantakopoulos G; Papakosta VM; Kontis D; Theochari E; Angelopoulos E; Zervas IM; Mellon RC; Papageorgiou CC; Tsaltas E
    J ECT; 2015 Dec; 31(4):246-52. PubMed ID: 25973768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ketamine Anesthesia Does Not Improve Depression Scores in Electroconvulsive Therapy: A Randomized Clinical Trial.
    Carspecken CW; Borisovskaya A; Lan ST; Heller K; Buchholz J; Ruskin D; Rozet I
    J Neurosurg Anesthesiol; 2018 Oct; 30(4):305-313. PubMed ID: 29847468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cognition in elderly patients receiving unilateral and bilateral electroconvulsive therapy: a prospective, naturalistic comparison.
    O'Connor DW; Gardner B; Eppingstall B; Tofler D
    J Affect Disord; 2010 Aug; 124(3):235-40. PubMed ID: 20053457
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurocognitive effects after brief pulse and ultrabrief pulse unilateral electroconvulsive therapy for major depression: a review.
    Verwijk E; Comijs HC; Kok RM; Spaans HP; Stek ML; Scherder EJ
    J Affect Disord; 2012 Nov; 140(3):233-43. PubMed ID: 22595374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of erythropoietin on cognitive side-effects of electroconvulsive therapy in depression: A randomized, double-blind, placebo-controlled trial.
    Miskowiak KW; Petersen JZ; Macoveanu J; Ysbæk-Nielsen AT; Lindegaard IA; Cramer K; Mogensen MB; Hammershøj LG; Stougaard ME; Jørgensen JL; Schmidt LS; Vinberg M; Ehrenreich H; Hageman I; Videbech P; Gbyl K; Kellner CH; Kessing LV; Jørgensen MB
    Eur Neuropsychopharmacol; 2024 Feb; 79():38-48. PubMed ID: 38128460
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ketamine administration in depressive disorders: a systematic review and meta-analysis.
    Fond G; Loundou A; Rabu C; Macgregor A; Lançon C; Brittner M; Micoulaud-Franchi JA; Richieri R; Courtet P; Abbar M; Roger M; Leboyer M; Boyer L
    Psychopharmacology (Berl); 2014 Sep; 231(18):3663-76. PubMed ID: 25038867
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinically favourable effects of ketamine as an anaesthetic for electroconvulsive therapy: a retrospective study.
    Kranaster L; Kammerer-Ciernioch J; Hoyer C; Sartorius A
    Eur Arch Psychiatry Clin Neurosci; 2011 Dec; 261(8):575-82. PubMed ID: 21400226
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Confirmatory Efficacy and Safety Trial of Magnetic Seizure Therapy for Depression (CREST-MST): study protocol for a randomized non-inferiority trial of magnetic seizure therapy versus electroconvulsive therapy.
    Daskalakis ZJ; Tamminga C; Throop A; Palmer L; Dimitrova J; Farzan F; Thorpe KE; McClintock SM; Blumberger DM
    Trials; 2021 Nov; 22(1):786. PubMed ID: 34749782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Administration of Sub-anesthetic Dose of Ketamine and Electroconvulsive Treatment on Alternate Week Days in Patients with Treatment Resistant Depression: A Double Blind Placebo Controlled Trial.
    Altinay M; Karne H; Anand A
    Psychopharmacol Bull; 2019 Feb; 49(1):8-16. PubMed ID: 30858635
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Electroconvulsive therapy in treatment resistant depression: What is new?].
    Kaliora SC
    Psychiatriki; 2021 Dec; 32(Supplement I):82-89. PubMed ID: 34990383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of COMT, DRD2, BDNF, and APOE Genotypic Variation on Treatment Efficacy and Cognitive Side Effects of Electroconvulsive Therapy.
    Bousman CA; Katalinic N; Martin DM; Smith DJ; Ingram A; Dowling N; Ng C; Loo CK
    J ECT; 2015 Jun; 31(2):129-35. PubMed ID: 25148110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of electroconvulsive therapy on neurocognitive function in treatment-resistant bipolar disorder depression.
    Kessler U; Schoeyen HK; Andreassen OA; Eide GE; Malt UF; Oedegaard KJ; Morken G; Sundet K; Vaaler AE
    J Clin Psychiatry; 2014 Nov; 75(11):e1306-13. PubMed ID: 25470096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autobiographical Memory Specificity in Major Depression Treated With Electroconvulsive Therapy.
    Jelovac A; OʼConnor S; McCarron S; McLoughlin DM
    J ECT; 2016 Mar; 32(1):38-43. PubMed ID: 26252557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A double-blind, placebo-controlled study of the impact of galantamine on anterograde memory impairment during electroconvulsive therapy.
    Matthews JD; Siefert CJ; Blais MA; Park LT; Siefert CJ; Welch CA; Dubois CM; van Nieuwenhuizen AO; Rooney KO; Seabrook RC; Durham LE; Adams HC; Fava M
    J ECT; 2013 Sep; 29(3):170-8. PubMed ID: 23519225
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Using the Cambridge Neuropsychological Test Automated Battery (CANTAB) to assess the cognitive impact of electroconvulsive therapy on visual and visuospatial memory.
    Falconer DW; Cleland J; Fielding S; Reid IC
    Psychol Med; 2010 Jun; 40(6):1017-25. PubMed ID: 19775495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cognitive effects of brief and ultrabrief pulse bitemporal electroconvulsive therapy: a randomised controlled proof-of-concept trial.
    Martin D; Katalinic N; Hadzi-Pavlovic D; Ingram A; Ingram N; Simpson B; McGoldrick J; Dowling N; Loo C
    Psychol Med; 2020 May; 50(7):1121-1128. PubMed ID: 31056081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.